Primary economic evaluations are needed in the case that the systematic review of existing economic evidence is not capable of informing economic profiles of marketed medicines.

• 摘要当现有经济学证据的系统评价不能充分评价上市后药物的经济学情况时，需要开展原始的经济学评价研究。